Production of diverse PET probes with limited resources: 24 18 F-labeled compounds prepared with a single radiosynthesizer

Authors:

Abstract
Significance: Molecular imaging with PET can provide a dynamic, whole-body picture of the rate of biological processes or distribution of biological targets by tracking the distribution of radiolabeled molecules or particles in the body over time. Continual efforts to develop new PET probes are expanding the variety of processes and targets that can be visualized, facilitating basic research, drug development, and patient care. However, access to these probes at all stages of their development is hindered by high costs arising, in large part, from the significant resources that are typically dedicated to production of a single probe. Emerging technologies with increased synthesis flexibility are allowing increased probe diversity with fewer resources and could significantly increase access to new molecular imaging agents.
Funding Information
  • HHS | NIH | National Institute of Biomedical Imaging and Bioengineering (R21EB015540)
  • HHS | NIH | National Institute of Biomedical Imaging and Bioengineering (R43EB0223782)
  • HHS | NIH | National Institute on Aging (R21AG049918)
  • HHS | NIH | National Cancer Institute (R21CA174611)
  • HHS | NIH | National Cancer Institute (R21CA186842)
  • HHS | NIH | National Cancer Institute (P50 CA092131)
  • U.S. Department of Health and Human Services (HHSN261201400041C)
  • HHS | NIH | National Cancer Institute (U54CA151819)
  • U.S. Department of Energy (DE-SC0001249)
  • U.S. Department of Energy (DE-SC0012353)
  • U.S. Department of War (W81XWH-15-1-0725)

This publication has 51 references indexed in Scilit: